Winvest Group Ltd
A highly leveraged OTC issuer reporting consistent net losses and volatile cash flows with minimal revenue generation over the last five years.
A highly leveraged OTC issuer reporting consistent net losses and volatile cash flows with minimal revenue generation over the last five years.
Investors might consider WNLV as a deep-value turnaround play where current distressed metrics like negative working capital and accumulated deficits represent temporary anomalies rather than permanent structural failures. The company's ability to secure financing cash flows exceeding $200M suggests potential for aggressive debt restructuring or strategic pivots that could unlock hidden value in its long-term asset portfolio.
Avoidance is warranted due to the persistent pattern of negative net income over three consecutive years, a current ratio well below 1.0 indicating imminent solvency concerns, and minimal revenue growth that fails to cover interest expenses. The substantial retained earnings deficit combined with high accrued liabilities creates a precarious financial structure with limited capacity to withstand market volatility or operational shocks.
Winvest Group Ltd. (WNLV) is a specialized OTC-listed entity with limited disclosed revenue streams, primarily characterized by significant accumulated liabilities and recurring operating losses. The company operates in a niche market where its balance sheet reflects heavy leverage relative to its small asset base, suggesting high-risk speculative investment characteristics rather than traditional operational stability.
Recent financial performance highlights a severe deterioration in operational efficiency with operating profit dropping to -$762M and cash flow from operations turning significantly negative at -$351M. Despite a one-time cash injection from financing activities totaling $225M, the company failed to convert this liquidity into sustainable earnings, resulting in a net loss of $1.1M while current assets shrank relative to liabilities.
The OTC equity market often hosts emerging entities or distressed firms where liquidity is fragmented and information asymmetry is high, creating an environment of elevated risk for investors seeking traditional growth metrics. Companies in this space frequently struggle with maintaining regulatory compliance while attempting to navigate complex balance sheet restructuring challenges common in niche financial sectors.
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $89.3K | $339.9K | $77.3K |
| Cost of Revenue | $51.7K | $120.9K | $80.0K |
| Gross Profit | $37.5K | $219.1K | $-2.7K |
| Operating Expenses | $2.4M | $1.1M | $-760.3K |
| Operating Income | $-2.3M | $-863.7K | $-763.0K |
| G&A | $366.4K | $1.1M | $760.3K |
| Stock-Based Comp | — | $458.0K | — |
| D&A | $210.5K | — | — |
| Amortization | $210.5K | — | — |
| Other OpEx | $2.0M | $0 | $-1.5M |
| Non-Operating Income | $0 | $0 | $0 |
| Interest Expense | $2.1K | $11.8K | $3.6K |
| Pre-Tax Income | $-2.3M | $-863.7K | $-763.0K |
| Income Tax | $2.0K | $11.8K | $0 |
| Continuing Ops | $-2.4M | $-875.5K | $-763.0K |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-2.4M | $-875.5K | $-1.1M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-2.4M | $-875.5K | $-1.1M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $220.6K | $126.1K | $303.2K |
| Cash & Equivalents | — | — | $181.5K |
| Accounts Receivable | $28.1K | $4.1K | $15.1K |
| Prepaid Expenses | — | — | $550.0K |
| Other Current Assets | $192.5K | $122.0K | $-443.4K |
| Long-Term Assets | $0 | $1.9K | $14.4M |
| Goodwill | $1.0M | — | — |
| Other LT Assets | $-1.0M | — | — |
| Total Assets | $220.6K | $128.0K | $14.7M |
| Current Liabilities | $706.6K | $1.0M | $1.4M |
| Accounts Payable | $23.7K | $76.5K | $2.4K |
| Other Current Liab | $561.8K | $899.8K | $1.2M |
| Long-Term Liabilities | $0 | $0 | $100.0K |
| Total Liabilities | $706.6K | $1.0M | $1.5M |
| Shareholders' Equity | $-486.0K | $-902.6K | $13.2M |
| Paid-In Capital | $103.1M | $103.6M | $118.7M |
| Retained Earnings | $-103.8M | $-104.7M | $-105.8M |
| Total L&E | $220.6K | $128.0K | $14.7M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-2.4M | $-875.5K | $-1.1M |
| Non-Cash Adjustments | $1.7M | $660.8K | $260.9K |
| Working Capital Changes | $306.9K | $-15.4K | $469.0K |
| Cash from Operations | $-385.7K | $-230.1K | $-351.1K |
| Cash from Investing | $29.8K | $0 | $262.0K |
| Cash from Financing | $393.0K | $238.0K | $225.5K |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $37.1K | $7.9K | $136.5K |
| Beginning Cash | $0 | $37.1K | $45.1K |
| Ending Cash | $37.1K | $45.1K | $181.5K |
The financial profile indicates a single dominant segment characterized by negative operating adjustments and massive accrued expenses, likely stemming from complex restructuring, litigation reserves, or specialized financial services not detailed in standard public filings.
The company faces severe liquidity risk with negative operating cash flows exceeding $350M in recent periods, significant accumulated retained earnings deficits over $100M, high leverage evidenced by current liabilities near $1.4M against only $303k in current assets, and the danger of regulatory scrutiny due to OTC delisting standards for sustained losses.
Primary advantages include potential access to alternative capital markets via OTC listing, the ability to restructure legacy liabilities through non-cash accounting adjustments, and a low cost of goods sold relative to its minimal revenue base which theoretically allows for margin expansion if operations normalize.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.